This medication was recently proven to be non-inferior to cyclophosphamide for the induction of ANCA vasculitis.

See Image 1

This medication has the potential to cause proteinuria and TTP as complications.

See Image 2

A positive Anti-PLA2R Ab is strongly suggestive of the primary form of this disease.

See Image 3

This drug is a terminal C5 inhibitor and is the ideal treatment for PNH.

See Image 4

This drug can cause both membranous nephropathy and ANCA vascultis.

See Image 5